ANEB
Anebulo Pharmaceuticals, Inc.$0.2750 −0.01 (−5.17%)
Oct 26 4:00 PM ET · prev $0.2900
Next earnings
Nov 11
in 15 days
1 year
−89.8%
from $2.70 · Oct 27
30 days
−14.1%
from $0.3200
52-week range
$0.001000–2.71
−90% from high · low Jul 15
Avg volume 20D
185
Oct 19 spike 1.1K
Short interest
🔒 Subscribers only
New fund stakes
0
Q4 2025 13F · 0 exits
Filing reports
1
analyzed by SecBot
SecBot read BEARISH 1 report · latest
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 11, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- R Mar 2 Anebulo Pharmaceuticals, Inc. (ANEB) has filed Form 15-12G to termin…
- X Sep 15 Short interest jumps 6838.5% to 391.0K
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q4 2025: 2 added (0 new), 1 trimmed or exited.
- TrendDOWNTREND
12% below its 50-day average.
Who's buying
13F· Q4 20250
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| VANGUARD GROUP INC | ADD | $440.2K |
| UBS Group AG | DOUBLED | $2.4K |
| BANK OF AMERICA CORP /DE/ | TRIM | $386.00 |
| VANGUARD GROUP INC | ADD | $766.4K |
| BlackRock, Inc. | ADD | $60.1K |
| BANK OF AMERICA CORP /DE/ | TRIM | $2.2K |
| UBS Group AG | DOUBLED | $550.00 |
| GOLDMAN SACHS GROUP INC | NEAR_EXIT | $16.7K |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
last action Jul 2025Recent actions
| Date | Firm | Rating |
|---|---|---|
| Jul 23, 2025 | Maxim Group DOWNGRADE | Hold |
| May 15, 2025 | Maxim Group MAINTAIN | Buy |
| Nov 19, 2024 | Benchmark REITERATE | Speculative Buy |
| Oct 1, 2024 | Benchmark REITERATE | Speculative Buy |
| Oct 3, 2023 | Benchmark REITERATE | Speculative Buy |
| Sep 25, 2023 | HC Wainwright & Co. REITERATE | Buy |
Earnings setup
EstimatesNov 11
reports in 15 days
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Oct 15, 2026
Earnings date
ANEB Q4 2026 Earnings After Market Close — 2026-10-15
Sep 30, 2026
Earnings date
ANEB Q4 2026 Earnings After Market Close — 2026-09-30
Sep 28, 2026
Earnings date
ANEB Q4 2026 Earnings After Market Close — 2026-09-28
May 7, 2026
Earnings date
ANEB Q3 2026 Earnings Scheduled — 2026-05-07
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 15, 2026 Earnings calendar
Mar 2, 2026 SEC ANEB Q4 2026 Earnings After Market Close — 2026-10-15
Anebulo Pharmaceuticals, Inc. (ANEB) has filed Form 15-12G to terminate the registration of its Common Stock under…
15-12G — Impact 7/10
Dec 31, 2025 Inst.
VANGUARD GROUP INC — ADD
435,821 shares ($440.2K)
Dec 31, 2025 Inst.
UBS Group AG — DOUBLED
2,334 shares ($2.4K)
SecBot reports
1 filing · 0 bullish · 1 bearishAll ANEB filing & press-release reports (1)
- 15-12G reportMar 2, 2026